Vivos Therapeutics, Inc. (VVOS)
NCM – Real vaqt narxi. Valyuta: USD
0.45
+0.01 (3.13%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.45
-0.00 (-0.13%)
Bozordan keyin: Jun 26, 2026, 6:39 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.45
+0.01 (3.13%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.45
-0.00 (-0.13%)
Bozordan keyin: Jun 26, 2026, 6:39 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $12.3M naqd pul zahiralaridan ($2.1M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy majburiyatlar $17.9M jami joriy aktivlardan $4.8M oshib ketdi, likvidlik muammolarini ko'rsatadi
Qarz/kapital nisbati (-9.7) tarmoq o'rtachasidan (1.1) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$6.0M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 0.27 | 3.40 | 3.0 | |
| Tezkor likvidlik nisbati | 0.27 | 2.52 | 3.0 | |
| Qarz/Kapital nisbati | N/A | 1.11 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.49 | 1.58 | 5.0 | |
| Foiz to‘lov qoplami | N/A | 4.33 | 1.0 | |
| O‘rtacha ball | 2.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 16M | 14M | 15M | 17M | 20M |
| Yalpi foyda | 9M | 8M | 8M | 9M | 11M |
| Operatsion daromad | -25M | -17M | -11M | -20M | -23M |
| Sof foyda | -24M | -14M | -11M | -21M | -25M |
| EBITDA | -24M | -17M | -11M | -19M | -21M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 45.78 | 32.73 | 10 |
| Keyingi chorak | -10.53 | 36.73 | 5.5 |
| Joriy yil | 33.31 | 32.13 | 10 |
| Keyingi yil | 48.4 | 40.21 | 10 |
| O‘rtacha ball | 8.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 34.44 | -11.42 | 10.34 | -12.81 | 4.8 |
| Yil/Yil | 70.46 | -98.8 | -15.55 | -53.84 | 3.3 |
| 3 yil o‘rtacha | 3.7 | -9.67 | 47.99 | 0.36 | 4.3 |
| 5 yil o‘rtacha | 7.05 | -15.22 | 28.58 | -44.91 | 4.3 |
| O‘rtacha ball | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |